IMMUNOLOGY...the video game? OK I was trying to follow

New Post Public Reply Private Reply Replies (0) Message Board
Lee Ron Lemab
836
IMMUNOLOGY ...the video game?

OK I was trying to follow the recipe of Respert24, but my wine cabinet and literary skills left much to be desired, and my frozen dinners do not compare to his steaks. Nonetheless, I had a BLAST! And in my mind so did covid. (Segway, check!)

Preamble: (trying to sound fancy here, bear with me)

The world is full of constant talk of fighting viruses and diseases. Video games have been made to focus on the high score or beat Donkey Kong or Bowser.

Why not shift the focus of video games to what's on the minds of kids and adults alike in today's world: fighting viruses and diseases. I took a buzzy moment to think of what this could look like… and I thought…

The goal: TO SURVIVE


Game play:

The challenge: You are faced with troublesome news. You have been diagnosed with COVID-19. The game starts upon first symptoms (fever, loss of taste) so you have time to beat the disease and save your life (there are no 1ups in this game). This is life, not a game! Wait, its a game about life… Wine check! Check plus!! And away we go. (Take that Respert24… muhuhahahahaaaaa.)

The intro graphic appears: You have covid. "But I was so safe!" Are you gonna lie down? or are you gonna fight?? or are you gonna fight by lying down??? You choose one of the three choices and proceed.

The intro music billows in your ears like a songbird, then changes to hardcore rap, jarring you to the harsh reality of the casual effort put in by the game designer while he sips his cheap wine…

Emimem comes on the screen and says in a rappy way: Sorry about your diagnosis. Look, if you only had one shot, one opportunity…to seize everything you ever wanted in one moment…. Would you capture it or just let it slip? This is your life. The choice is yours."

(As Homer Simpson would say “I think he’s talking to you! )


Two buttons appear:

1) FIGHT!
2) Quit

Upon choosing FIGHT, you are shrunken like the scene in Innerspace (yes Innerspace) and injected into the body. You are armed with a needle, not a gun.

Your ammo: All the known medicines in the world are in your arsenal!! And you’ve been studying this IH forum like its your job cause they ain’t watchin!!

(This is where it gets good, it had to eventually, or did it?)

Your choice: Which medicine are you gonna use to fight covid??

See here for your weapon of choice… there can be only one!! (I didn’t see no copyright): https://www.nytimes.com/interactive/2020/scie...ments.html


Game play : You jump onto blood cells and epithelial cells and other fancy sounding cells and use your weapon where you see best fit: on CCR5 receptors, the ACE proteins, maybe stem cells. Maybe you find your way to the back of the throat and hit it with some propolis? You are also armed with…. Google, so you pause the game to google “propolis” and carry on.

During the fight mid-game choices appear before you, prompting you to decide foods to eat that can help or hurt your ability to survive. Choices include eating anti-inflammatory foods like:

Eat some beat roots?
Munch on some moringa??
You know you want the Big Mac tho!!!

Sit in the sun for 1 hour a day (for Vitamin D)? or stay inside and rest more??

Likelihood of survival is increased or decreased by the choices you make. Studies supporting the effect of your choice on survival appear as hyperlinks to web articles showing study data.


Upon choosing Leronlimab (the only way to solve the game of course) you have two subcutaneous needles that spray leronlimab on CCR5… and you solve the game and have no need to save a fake princess.



The sequel: HIV

The cheat code: Leronlimab (case sensitive)

The disclaimer: I know I don’t know any of you. I just feel we have all been beaten down by this pandemic and there’s not much we can do to help our loved ones and ourselves. While I enjoy a good laugh, when it comes to COVID 19, I do not believe laughter is the best medicine, I believe leronlimab is. While we have to wait even longer to see it become a reality due to various reasons, why not have a laugh?

Thanks for being such an informative and caring group of individuals rather than a bunch of money grubbing short-sided individuals. “The Brinks truck doesn’t follow the hearse” as my grandparents would say.

My ask: Please reply with your most insightful article on leronlimab, CCR5 antagonist research against cancer, NASH, HIV, anything. However best helpful to contribute to a consolidated “pile” of info. I have been a member for a while now and I’m experiencing major information saturation. I know many are too, and I’m looking to help with that.

Perhaps your 1 paragraph pitch on “Why Leronlimab?” Yeah, that would hit the proverbial spot.

I want to post to the yahoo forum with insight to help people learn what our media has not taught us, and I’m counting on… You! (Insert picture of Uncle Sam here). And yeah I know TechGuru provided a detailed guide of how to post an image, and I bookmarked it on one of my 4 private browsers, but I’m more info saturated than the influence of hypoxia on upregulation of ACE2 (target receptor for SARS-CoV-2 entry) expression, with supporting transcriptomic analysis of a publicly available gene expression profile dataset of human renal proximal tubular epithelial cells cultured in normoxic or hypoxic conditions!

So either diffuse my systemic endothelitis and microthrombi playing an important pathogenic role in the wide range of systemic manifestations, exacerbation of hypoxic pulmonary vasoconstriction in the setting of pulmonary vascular endothelitis/microthrombi, the phenomenon of “silent hypoxemia” with some patients presenting to the hospital with severe hypoxemia disproportional to symptoms… Or post your favorite CCR5 antagonist link.

Thanks for playing.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZEISS Expands in China: Tackling Myopia's Surge

Updated Category News Views 157

ZEISS Sets Sights on China’s Myopia Epidemic They're calling myopia a public health crisis in China, and if you've seen the statistics, that's no exaggeration. Enter ZEISS Medical Technology, angling for a piece of the pie with their newly NMPA-approved PT LUNANA phakic intraocular lens. This is more than just another medical product, folks. It's a strategic entry into...

Continue Reading
Keenova Q3 2026: Net Sales Up, Losses Shrink

Updated Category News Views 29

A Strong Quarter Despite Some Knocks It ain't every day you see a company like Keenova Therapeutics clocking solid top-line growth, despite battling the waves of operational losses. Now, don't get me wrong; I ain't swooning over their near $96 million loss from continuing operations, but let me give credit where it's due—those sales numbers popped impressive. Pillars of...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 109

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Grandparents' Holiday Gift Picks: Expertly Tested Ideas

Updated Category News Views 21

Hunting for the Perfect Gift? Look No Further The holiday hustle and bustle inevitably sparks one of the annual dilemmas: What on earth should you buy those grandkids of yours? No need to get all twisted up this season. Enter ZestYears, the savvy go-to guide for grandparents who want to nail gift-giving without breaking a sweat or the bank. These folks, based out of...

Continue Reading
Kelley Blue Book Hits 100: Celebrating on Route 66

Updated Category News Views 36

If you've ever punched numbers on car values, you've probably bumped into Kelley Blue Book. This icon in vehicle valuation is marking its 100th birthday with a bang—road-tripping across Route 66 to sprinkle some joy across the dusty roads of history. Nostalgia Meets the Open Road The legendary Route 66 is not just the backdrop but the beating heart of this centennial...

Continue Reading
Tampa General Tackles Housing with The Linden Launch

Updated Category News Views 93

Building Bridges Between Work and Home Well, it’s about time someone threw in a lifeline to those drowning in Florida’s housing crisis. Tampa General Hospital, teaming up with The Michaels Organization, is setting the stage with 'The Linden': a solution pitched smack dab into the heart of affordability woes. This isn't your run-of-the-mill press release fluff. They've...

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 24

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Caladan and NextBlock's Move Expands Crypto Liquidity

Updated Category News Views 55

Partnership to Expand Digital Asset Liquidity Looks like Caladan and NextBlock just threw their hats in the ring to shake up South Korea’s institutional digital asset market. These two big guns have cooked up a strategic collaboration, aiming to bring more global liquidity into the mix. Dive into what this means for the digital asset scene in South Korea. Why This Move...

Continue Reading
Giti Tire Hits Jaw-Dropping Speeds with Record-Breaker

Updated Category News Views 78

Blazing a New Trail in Automotive Excellence Who would've thought rubber on road could hit a jaw-dropping 503.17 km/h (312.65 mph)? Giti Tire just broke the mold, etching its name into the history books with the Guinness World Records™ title for their GitiSport e.GTR2 Pro tires. This isn't just about speed—it's about engineering marvel and pushing boundaries in...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 81

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Corgan's Survey Insights Shape Future of Multifamily Living

Updated Category News Views 170

Corgan's New Report on the Multifamily Housing Sector Corgan, a leading global architecture and design firm, has made significant strides by unveiling its latest research report titled Residency Reshaped. This comprehensive study focuses on the evolving landscape of the multifamily housing market as it addresses the changing preferences of renters. As the world shifts...

Continue Reading
Savor $5 Chicken Delights at 7-Eleven Restaurants

Updated Category News Views 111

Exciting $5 Chicken Deals at 7-Eleven Restaurants 7-Eleven, Inc. is making waves in the culinary scene with its latest promotion featuring delightful $5 chicken options. Customers can indulge in comfort foods that won’t break the bank, perfect for lunch breaks, quick snacks, or effortless dinners. Flavorful Offerings to Enjoy The chain is rolling out an array of options...

Continue Reading
Auddia Inc. Explores Growth with Major Strategic Move

Updated Category News Views 148

Exciting Transformations at Auddia Inc. In a bold step towards innovation, Auddia Inc. (NASDAQ: AUUD) and NASDAQ: AUUDW are embarking on a strategic transformation aimed at elevating their portfolio through advanced technologies such as AI and blockchain. The company has recently entered into a non-binding letter of intent (LOI) with Thramann Holdings, LLC, marking a...

Continue Reading
Volvo Group Reports Q3 2024 Results and Market Dynamics

Updated Category News Views 298

Volvo Group Q3 2024 Financial Overview During the third quarter of 2024, the Volvo Group observed a noticeable shift in demand across several markets. Martin Lundstedt, President and CEO, highlighted that freight and construction activities have seen a decline compared to the previous year. This trend has resulted in a 7% decrease in net sales, which amounted to SEK 117.0...

Continue Reading
Unveiling ClinPhone 5: Transforming Clinical Research Dynamics

Updated Category News Views 418

Perceptive eClinical Launches ClinPhone 5 Perceptive eClinical, a division of Perceptive Group, is excited to introduce ClinPhone 5, a next-generation Randomization and Trial Supply Management (RTSM) platform. This innovative solution has been meticulously developed in collaboration with CRScube, a prominent clinical research technology provider from South Korea. The goal...

Continue Reading